Antidepressant effect of methanol root bark extract of Acacia seyal Del. (Fabaceae): Possible involvement of the inflammatory pathway
Purpose: To study the involvement of inflammatory pathways in the antidepressant activity of Acacia seyal in mice.
Methods: The median lethal dose (LD50) of the extract Acacia seyal (AS) was determined using OECD guideline 425. The antidepressant activity of AS was assessed against BCG (0.2 mg/kg, ip)-induced depression in mice using Tail suspension test (TST) and open field test (OFT) at 4, 24 and 48 hours post BCG administration.
Results: The median lethal dose (LD50) for the extract was > 5000 mg/kg orally. The extract AS at all tested doses (250 – 1000 mg/kg) significantly (p ≤ 0.001) decreased the duration of immobility in TST but increased the number of line crossing in OFT post-BCG.
Conclusion: The antidepressant activity of the methanol root bark extract of Acacia seyal in mice may involve an inflammatory mechanism. Thus, the extract of Acacia seyal may be suitable for the management of depression in humans resistant to other conventional antidepressant agents. However, further studies are required to ascertain this
Keywords: Depression, Acacia seyal, Tail suspension test, Open field test, Bacillus Calmette-Guerin
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.